SCHEMBL10691782

SCHEMBL10691782

CCCC(=O)Oc1ccc(N2C(=O)CCC2c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HPGD P15428 1/20 0.44
TNKS O95271 2/20 0.43
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CCNA1 P78396 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
SLC18A3 Q16572 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
BCL9 O00512 1/20 0.40
CTNNB1 P35222 1/20 0.40
ESR1 P03372 2/20 0.39
PTGER4 P35408 1/20 0.39
PTGER2 P43116 1/20 0.39
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997448 0.84 GLA (0.52) KMT2ATNKSCCNA2CDK2CCNA1
SCHEMBL10572047 0.77 TNKS (0.43) KMT2ASMN1; SMN2HPGDTNKSCCNA2
SCHEMBL3739324 0.75 HDAC6 (0.54) TNKSCCNA2CDK2CCNA1HDAC1
SCHEMBL6789099 0.74 TNKS (0.48) TNKSCCNA2CDK2CCNA1HDAC1
SCHEMBL3584808 0.73 ALDH1A1 (0.49) TNKSCCNA2CDK2CCNA1HDAC1
SCHEMBL14155611 0.73 HDAC1 (0.55) KMT2ATNKSCCNA2CDK2CCNA1
SCHEMBL3586685 0.73 ALDH1A1 (0.49) TNKSCCNA2CDK2CCNA1HDAC1
SCHEMBL6783997 0.72 CCNA2 (0.60) KMT2ASMN1; SMN2TNKSCCNA2CDK2
SCHEMBL5591295 0.72 LMNA (0.53) TNKSCCNA2CDK2CCNA1HDAC1
SCHEMBL10574183 0.72 TDP1 (0.55) KMT2AL3MBTL1TDP1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0270093-A2 Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties TANABE SEIYAKU CO., LTD. (JP) 1988-06-08 EP disclosed